Do you suffer from inadequately controlled Asthma?
This clinical research study is looking at the safety and effectiveness of a medication for people with persistent asthma. Asthma is a condition in which your airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing) when you breathe out, and shortness of breath.
The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma.
Would you like to contribute to medical research?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your asthma to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others with asthma, and whether it will be made widely available to all Canadians with asthma. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Have been diagnosed with asthma for at least 3 months before beginning the study
- Are either:
- Untreated for asthma with any medications
- Are currently treated with daily maintenance ICS or ICS/LABA for your asthma
- Are able to complete mandatory study questionnaires in line with the requirements of the study protocol
You may not qualify to participate if you:
- Have a recent history of life-threatening asthma
- Have a history of at least 1 severe exacerbation of asthma within 12 months prior to randomization
- Are of childbearing potential and are not following at least one highly effective method of contraception. This includes those who are pregnant or lactating or are planning to become pregnant during the study.
- Have been exposed to inhaler triple therapy and/or any LAMA-containing therapy within 12 months prior to joining the study
- Have ongoing need for biological therapy or recent use of a biological therapy
- Have been diagnosed with chronic obstructive pulmonary disease (COPD)
- Have made changes to your asthma medication within 3 months prior to joining the study
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.
